Fulltext for PDF in Flash Viewer:

RESEARCH ARTICLE 2605 Development 134, 2605-2614 (2007) doi:10.1242/dev.02859 A Drosophila ortholog of the human cylindromatosis tumor suppressor gene regulates triglyceride content and antibacterial defense Theodore Tsichritzis1, Peer C. Gaentzsch3, Stylianos Kosmidis2, Anthony E. Brown3, Efthimios M. Skoulakis2, Petros Ligoxygakis3,* and George Mosialos1,4,* The cylindromatosis (CYLD) gene is mutated in human tumors of skin appendages. It encodes a deubiquitylating enzyme (CYLD) that is a negative regulator of the NF- B and JNK signaling pathways, in vitro. However, the tissue-specific function and regulation of CYLD in vivo are poorly understood. We established a genetically tractable animal model to initiate a systematic investigation of these issues by characterizing an ortholog of CYLD in Drosophila. Drosophila CYLD is broadly expressed during development and, in adult animals, is localized in the fat body, ovaries, testes, digestive tract and specific areas of the nervous system. We demonstrate that the protein product of Drosophila CYLD (CYLD), like its mammalian counterpart, is a deubiquitylating enzyme. Impairment of CYLD expression is associated with altered fat body morphology in adult flies, increased triglyceride levels and increased survival under starvation conditions. Furthermore, flies with compromised CYLD expression exhibited reduced resistance to bacterial infections. All mutant phenotypes described were reversible upon conditional expression of CYLD transgenes. Our results implicate CYLD in a broad range of functions associated with fat homeostasis and host defence in Drosophila. KEY WORDS: Cylindromatosis, Drosophila, Fat body, Host defense, NF-kappaB INTRODUCTION Familial cylindromatosis is an autosomal-dominant predisposition to tumors of skin appendages called cylindromas (Bignell et al., 2000). This familial disease and the majority (57%) of sporadic cases of cylindromatosis are causally associated with defects in a single gene, named CYLD (Biggs et al., 1996; Biggs et al., 1995). Tumors develop in individuals who have both copies of the gene inactivated, indicating that CYLD is a tumor suppressor gene. CYLD codes for a 956 amino acid cytoplasmic protein (CYLD) with deubiquitylating activity, which has been associated genetically with its tumor-suppressing function (Borodovsky et al., 2002; Kovalenko et al., 2003; Trompouki et al., 2003). CYLD is also a negative regulator of NF- B activation by members of the tumor necrosis factor receptor superfamily (Brummelkamp et al., 2003; Kovalenko et al., 2003; Regamey et al., 2003; Trompouki et al., 2003). The negative regulation of this pathway appears to be mediated by the ability of CYLD to induce deubiquitylation of TRAF2, TRAF6 and/or NEMO [also known as IKBKG and IKK � Human Gene Nomenclature Database (HUGO)]. Interestingly, mice with both Cyld alleles inactivated are more susceptible to chemically induced skin cancer than wild-type mice and their susceptibility is a consequence, at least in part, of increased Bcl3-dependent NF- B activity (Ikeda and Dikic, 2006; Massoumi et al., 2006). Recent reports have indicated a broader role for CYLD in mammalian pathophysiology, consistent with its broad tissue distribution. This protein is drastically downregulated in human inflammatory bowel Institute of Immunology and 2Institute of Molecular Biology and Genetics, Biomedical Sciences Research Center Al. Fleming, 34 Al. Fleming Street, 16672 Vari, Greece. 3Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK. 4Department of Biology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. *Authors for correspondence (e-mail: petros.ligoxygakis@bioch.ox.ac.uk; mosialos@fleming.gr) Accepted 11 April 2007 1 disease and it is required for the proper development of T lymphocytes in mice (Costello et al., 2005; Reiley et al., 2006). CYLD is significantly conserved across evolution, because putative orthologs of CYLD can be readily identified in a variety of organisms, including Drosophila melanogaster and Caenorhabditis elegans (Bignell et al., 2000). The broad tissue distribution of CYLD, its implication in two complex and highly regulated signaling pathways, and the fact that multiple tissues are affected when the gene is mutated highlight the complexity of the biological roles of this protein. To facilitate the functional characterization of CYLD, we sought to establish and characterize a simpler, yet appropriately representative, animal model system. Drosophila was chosen for this analysis, because it is well-characterized, offers enormous advantages for genetic analysis and contains a putative ortholog of CYLD. Drosophila CYLD (FlyBase gene ID: CG5603) is 45% homologous to human CYLD and the two proteins have a similar domain organization (Bignell et al., 2000). Based on previous findings using human cells, we sought to validate the model by investigating the involvement of Drosophila CYLD in NF- B/IKK signaling. In this context, we analyzed the potential involvement of Drosophila CYLD in IMDmediated innate immunity. In Drosophila, IMD (for immune deficiency) defines a signaling cascade broadly resembling the mammalian TNFR1 (also known as TNFRSF1A � HUGO) pathway (Kaneko and Silverman, 2005; Naitza and Ligoxygakis, 2004). Following microbial recognition via the Drosophila peptidoglycan recognition proteins (PGRPs) PGRPLC and PGRP-LE, the signal is transduced from the cell surface to IMD, a central player of the pathway and a homolog of the mammalian TNF receptor interacting protein 1 (RIP1) (Georgel et al., 2001). In the TNFR1 pathway, RIP1 is essential for NF- B and mitogen activated kinase (MAPK) activation (Kelliher et al., 1998; Stanger et al., 1995). In Drosophila, IMD transduces a signal that involves similar components. Flies deficient in IMD, dFADD (also known as BG4 � FlyBase) or dTAK1 (also known as TAK1 � DEVELOPMENT 2606 RESEARCH ARTICLE Development 134 (14) frame (ORF) was cloned into the EcoRI-XhoI site of pAc5.1/c-MYC-HIS A using the following PCR primers: AcCYLD-F: 5 -CCCGAATTCCAAAATGATCTTAAACAACAAAAGTAAAAC-3 and AcCYLD-R: 5 CCCCTCGAGATGGTACATCATTATATCTGTGC-3 . Plasmid pAc5.1/cMYC-HIS A was generated by replacing the V5 epitope of plasmid pAc5.1/V5-HIS A (Invitrogen) with a c-MYC epitope by ligating the following annealed phosphorylated oligos into BstBI�AgeI-digested pAc5.1/V5-HISA: cMyc-S, 5 -CGAAGAACAAAAACTTATTTCTGAAGAAGATCTGA-3 and cMyc-AS, 5 -CCGGTCAGATCTTCTTCAGAAATAAGTTTTTGTTCTT-3 . V5 and 6 HIS C-terminal-tagged kenny (key), the full-length key ORF, was PCR amplified from the cDNA clone LD18356 (Drosophila Genomics Resource Center) using the following primers: AcKEY-F, 5 -CCCGAATTCCAAAATGTCGGACGAAGAGTCATTC-3 and AcKEY-R, 5 -CCCCTCGAGGTTTTTATCCAAACAATCGTTAACG-3 , and cloned into EcoRI-XhoI sites of the pAc5.1/V5-HIS A vector. Generation of anti-CYLD antibody FlyBase) are extremely sensitive to Gram-negative bacterial infections and fail to activate the relevant antimicrobial peptides (AMPs) (Leulier et al., 2002; Naitza et al., 2002; Vidal et al., 2001). The Drosophila I kinase (IKK) complex (see below) acts downstream of dTAK1 in the activation of NF- B. This complex contains two subunits identified by the ird5 and kenny (key) mutants. The former codes for the IKK homolog, whereas the product of the latter shares significant homology to the regulatory subunit of the human NEMO protein (Lu et al., 2001; Rutschmann et al., 2000b; Silverman et al., 2000). Activation of the IKK complex depends on the fly homologs of the ubiquitin-conjugating enzymes UBC13 (also known as UBE2N � HUGO) and UEV1 (also known as UBE2V1 � HUGO), similarly to the activation of mammalian IKK, which depends on the mammalian proteins (Deng et al., 2000; Wang et al., 2001; Zhou et al., 2005). The Drosophila IKK complex phosphorylates the precursor form of the Relish protein, an NF- B family member that can be activated by proteolytic cleavage. DREDD, a caspase-type protease, is involved in the full activation of Relish along with the Drosophila IKK complex (Stoven et al., 2003). Active Relish regulates directly the transcription of antimicrobial peptide genes. In this article, we show that, like its vertebrate counterpart, Drosophila CYLD is a deubiquitylating enzyme that is broadly expressed in embryos and adults. Flies with impaired CYLD expression are sensitive to bacterial infections, a phenotype that is reversed upon restoration of CYLD expression. In addition, we demonstrate that Drosophila CYLD is biochemically and functionally associated with the IMD pathway and that it regulates fat homeostasis. MATERIALS AND METHODS Plasmid construction The rabbit anti-CYLD antibody was generated by Santa Cruz Biotechnology using a GST fusion of Drosophila CYLD amino acids 1-317 as an antigen. Immunohistochemical analysis of Drosophila embryos Full-length D. melanogaster CYLD was amplified by PCR from D. melanogaster complementary (c)DNA using the primers: DMCYLDF1 (5 -GCTCTAGAATGAATTCCAAATCCGATTATGAAGC-3 ) and DMCYLDR4 (5 -CTGACCTACGCCGGCGGCTCTAATGGTACATCATTATATCTG-3 ). The resulting PCR product was digested with EcoRI and NotI, and was cloned into the corresponding sites of pCDNA3FLAG in frame with the FLAG epitope to generate pCDNA3FLAGDMCYLD (Trompouki et al., 2003). pCDNA3FLAGDMCYLD(C284S) was generated by three PCR reactions. The first PCR was performed with pCDNA3FLAGDMCYLD as the template and the primers DMCYLDF3 (5 -GGCTCGATACCACCATTACAAA-3 ) and DMCYLDR5 (5 -ATCAAGGTAGCTGGAATTATGG-3 ). The second PCR was performed with the same template and the primers DMCYLDF4 (5 -CACCATAATTCCAGCTACCTTGAT-3 ) and DMCYLDR6 (5 -CCGATGAGTGAAAGCTTTGC-3 ). The third PCR was performed with the products of the previous two PCRs as template and the primers DMCYLDF3 and DMCYLDR6 (see above). The resulting PCR product was digested with NdeI and HindIII and cloned into the NdeI and HindIII sites of pCDNA3FLADDMCYLD to generate pCDNA3FLAGDMCYLD(C284S). pUAST.1DMCYLD was generated by digesting pCDNA3FLAGDMCYLD with KpnI and XbaI and subcloning the fragment into the corresponding sites of the plasmid pUAST.1. pUAST.1DMCYLD(C284S) was generated in the same manner as pUAST.1DMCYLD. The full-length DMCYLD fragment produced from pCDNA3FLAGDMCYLD or pCDNA3FLAGDMCYLD(C284S) by digestion with EcoRI and NotI was cloned into pGEX5X3 (Amersham-Pharmacia Biotech) digested with EcoRI and NotI to generate glutathione-S-transferase (GST)-DmCYLD or GST-DmCYLD(C284S), respectively. GST-DmCYLD(1-317) was generated by cloning into the EcoRI and NotI sites of pGEX5X-3 a PCR fragment generated using pCDNA3FLAGDMCYLD as a template and the primers DMCYLDF1 and DMCYLDR2 (5 -GACTGGATGCGGCCGCCTGTAATTTCGAATATCTTGTGGGC-3 ) digested with EcoRI and NotI. To generate 6 HIS- and c-MYC-tagged Drosophila CYLD, the Drosophila CYLD-RC open reading Embryos from each developmental stage were dechorionated, fixed in 180 mM HEPES pH 6.9, 4 mM MgSO4 and 2 mM EGTA in 4% formaldehyde and 58.8% heptane, and rinsed with methanol. After rehydration with BBT [1 phosphate-buffered saline (PBS), 0.1% Tween20, 1% bovine serum albumin (BSA)], embryos were blocked with BBT250 (BBT, 250 mM NaCl) containing 2% normal goat serum (NGS) for 2 hours, stained with the appropriate primary antibody (400 ng/ml) overnight at 4�C, rinsed the following day with BBT-250 and stained with secondary antibody (1:2000 dilution) for 2 hours at room temperature. Finally, the embryos were rinsed with PBT (1 PBS, 0.1% Tween-20), stained with ABC reagent (Vectastain Elite HRP kit), developed with DAB solution (1 ml PBT, 1 mg DAB, 0.1% H2O2) and mounted in liquid Canada Balsam (Sigma). All antibodies were diluted in BBT-250 containing 2% NGS. Immunofluorescence analysis Sagittal paraffin sections (8 m) of entire adult flies were obtained and processed for immunohistochemistry as described previously (Philip et al., 2001; Skoulakis and Davis, 1996). The primary antibody was used at 5 g/ml and the secondary antibody at 1:2000. After washing, the sections were mounted with DAKO mounting medium (DAKO Corporation). All antibodies were diluted in PBHT (20 mM NaH2PO4, 500 mM NaCl, 0.2% Triton X-100, pH 7.4) containing 5% NGS. Staining with Nile red Female flies up to 5 days old were fixed for 5 hours at 4�C in PBS containing 4% paraformaldehyde. Subsequently, they were rinsed in PBS for 10 minutes at room temperature and were incubated overnight at 4�C in PBS containing 25% sucrose. The following day, the flies were placed in OCT (Sakura Finetek Europe) and were cryosectioned in 8 m sections. The sections were placed on gelatin-covered glass slides and rinsed for 10 minutes at room temperature in PBS. Subsequently, they were placed in Nile red solution (0.5 mg/ml Nile red in acetone) for 5 minutes at room temperature, and then they were rinsed three times with PBS and mounted with DAKO mounting medium (DAKO Corporation) for microscopy. Deubiquitylation assay MC1061 bacteria (Escherichia coli) expressing a ubiquitin-Met- galactosidase fusion were transformed with plasmids expressing GST, GSTCYLD(541-956), GST-CYLD or GST-CYLD(C284S). Overnight cultures of the transformants were diluted tenfold, grown for 1 hour and then incubated for 4 hours in the presence of 0.1 mM IPTG to induce the expression of GST fusion proteins. Cells (1.5 ml) were lysed in 150 l of cracking buffer (10 mM phosphate pH 7.4, 8 M urea, 1% SDS, 1% bmercaptoethanol) and boiled for 5 minutes. Extracts were subjected to SDS- DEVELOPMENT CYLD regulates fat content and host defense PAGE (6% gel) and western blotting with a rabbit anti- -gal antibody. Expression of GST fusion proteins was detected with SDS-PAGE (8.5% gel) and western blotting using anti-GST antibody. Analysis of Drosophila CYLD expression by RT-PCR RESEARCH ARTICLE 2607 a final wash with RIPA buffer alone. Immunoprecipitates were eluted by boiling in 2 SDS sample buffer, separated by 13% SDS PAGE, and transferred to PVDF membranes. Blots were probed with anti-V5 antibody (1:5000 dilution; Invitrogen). Drosophila stocks, infection experiments and northern blot analysis RNA was extracted from either eight male or five female flies or from the corresponding body parts using the RNA-Wiz kit (Ambion), according to manufacturer's instructions. cDNA was prepared using the Revert Aid cDNA synthesis kit (Fermentas), according to manufacturer's instructions. PCR analysis was performed using the primers DMCYLDF7 (5 -TAGAGCCGGAGGAACCTTTAC-3 ) and DMCYLDR9 (5 -GCATCTGTTGGCTGGTAC-3 ); DMCYLDF3 and DMCYLDR6; and rp49F1 (5 GATCGTGAAGAAGCGCAC-3 ) and rp49R2 (5 -CGCTCGACAATCTCCTTG-3 ) for loading control. Triglyceride content and starvation assay For triglyceride (TAG)-content analysis, three groups of eight male flies per genotype, approximately 36 hours old, were homogenized in 100 l 0.05% Tween-20, incubated at 70�C for 5 minutes and cleared twice by centrifugation at 5000 rpm (6150 g) for 1 minute and 13,000 rpm (16,000 g) for 3 minutes. Supernatants were analyzed for TAG content using a commercial kit (Biosis) according to manufacturer's instructions. Total protein was measured using the Bio-Rad DC Protein Assay kit (Bio-Rad) according to manufacturer's instructions. For the starvation assay, three groups of 25 male flies per genotype, approximately 36 hours old, were starved in food-free vials with unlimited water supply at 25�C. The death rate was estimated by counting the number of flies unable to exhibit a sit-up response in 12-hour intervals (Gronke et al., 2003). Yeast two-hybrid screening The following strains were made and used in this study: UAS-CYLD (wild type), UAS-CYLD/+; CYLDf00814;hs-Gal4/MKRS (CYLD rescue) and four insertions from the insertional mutagenesis stocks generated by Exelixis and made available to the fly community via the Bloomington Stock Centre. These were f00814 (CYLDf00814), f02494, d10472 and f00135. Df(2L)j27/CyO flies were obtained from the Bloomington Stock Center. We used a white isogenic strain as a wild-type control in all experiments. A white isogenic strain was used as a background by Exelixis in generating a series of different P element and piggyBac insertions (Thibault et al., 2004). Additional strains used were relish (Hedengren et al., 1999) and dif (Rutschmann et al., 2000a) as positive controls for Gram-negative and Gram-positive bacterial infections, respectively, and the yolkGAL4-drivercontaining strain (Georgel et al., 2001). To rescue the CYLDf00814 mutant phenotypes, strain UAS-CYLD/+; CYLDf00814;hs-Gal4/MKRS was incubated at 37�C for 1 hour followed by recovery at 29�C for 1 hour. All strains were analyzed by PCR for the presence of the Gram-negative bacteria Wolbachia and were found not to be infected. Bacterial immune challenge and northern blotting was performed as previously described (Rutschmann et al., 2000a). A cDNA corresponding to the full-length ORF of Drosophila CYLD was cloned into the LexA DNA-binding domain vector pHybLex/Zeo (Invitrogen). The resulting plasmid, pHyb-CYLD, was transformed into the Saccharomyces cerevisiae strain L40 [MATa his3 200 trp1-901 leu2-3112 ade2 LYS::(4lexAop-HIS3) URA3::(8)lexAop-lacZ) GAL4] (Invitrogen) and used as bait in a mating-based two-hybrid screen against other members of the IMD pathway (a full list of genes and PCR primer sequences is available upon request). Each pathway member was prepared by cloning their full-length cDNAs into the B42 activation-domain vector pYESTrp2 (Invitrogen) and transformed into the S. cerevisiae strain EGY48 (MAT ura3 trp1 his3 6lexAop-LEU2; Invitrogen). An interaction between JUN (bait; also known as JRA � FlyBase) and FOS (also known as KAY � FlyBase) using the abovementioned plasmids and yeast strains was employed as a positive control. Mating was performed by overlaying 1 l of an overnight culture of L40 flies with 1 l of EGY48 on a YPAD plate. Plates were incubated for 1-2 days at 30�C and diploids were selected. Activation of the lacZ reporter gene was tested according to the protocols outlined in the Hybrid Hunter handbook (Invitrogen). S2 cell culture and transfection RESULTS CYLD is broadly expressed during embryonic and adult stages of Drosophila development Drosophila contains a putative ortholog of the mammalian tumor suppressor gene CYLD. Five transcripts of Drosophila CYLD have been identified by genomic approaches (Fig. 1A, www.ensembl.org). The expression pattern of Drosophila CYLD was investigated by Drosophila S2 cells (Invitrogen) were maintained at 25�C in Schneider's Drosophila medium supplemented with 10% heat-inactivated FBS, 50 units ml�1 penicillin G, and 50 g/ml streptomycin sulfate (Invitrogen). Transfection was performed using the Effectene transfection reagent (Qiagen) according to the manufacturer's protocol. Briefly, 7.5 105 cells ml�1 were plated in 60 mm plates 24 hours before transfection. DNA (2 g) was used for each transfection using a 1:10 Effectene ratio. Cells were washed once in 1 PBS at 8 hours post-transfection and incubated at 25�C for 48 hours. Co-immunoprecipitation and western blot analysis Cell lysates were prepared from 5 ml cultures of transiently transfected cells with 2 g each of pAcCYLD/c-Myc and pAcKEY/V5 or 2 g of pAcKEY/V5 alone, in 100 l RIPA buffer (150 mM NaCl, 1.0% Igepal CA0630, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) (SigmaAldrich), supplemented with Complete Mini Protease Inhibitor Cocktail tablets (Roche Applied Science). Lysates were incubated with 100 l of antic-MYC agarose affinity gel (Sigma-Aldrich) for 1.5 hours with agitation rocking at room temperature. Immunoprecipitates were washed with CoIP buffer (900 mM NaCl, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0) six times, each for 10 minutes, followed by Fig. 1. Reverse transcriptase-PCR analysis of CYLD expression in Drosophila melanogaster. (A) Five transcripts of Drosophila CYLD have been described, and are shown here. The positions of the CYLD primers used in B (DCYF3 and DCYR6) are shown. (B) CYLD (DmCYLD) expression was detected by reverse transcriptase (RT)-PCR using the primers DMCYLDF3 (DCYF3) and DMCYLDR6 (DCYR6), and RNAs were isolated at the indicated developmental stages and in the indicated body compartments of adult w1118 flies (upper panel). RP49 (also known as RpL32) RNA was used as a control for the amount of cDNA used in the RT-PCR reaction (lower panel). DEVELOPMENT 2608 RESEARCH ARTICLE Development 134 (14) Fig. 2. Distribution of CYLD in Drosophila embryos and adults. (A-D) Detection of CYLD in embryos by immunohistochemistry. (A) At stage 7, CYLD is expressed in the anterior midgut rudiment (amg), in the posterior midgut rudiment (pmg) and in the mesoderm (ms). (B) At stage 12, CYLD is localized in the developing brain area (br), in the forming midgut (amg and pmg) and in the ventral nerve cord (vnc). (C) At stage 14, CYLD is detected at the brain (br), the ventral nerve cord (vnc), the midgut (mg) and the hindgut (hg). (D) Stage 12 embryos homozygous for the Df(2L)J21 deficiency, which deletes the CYLD locus, did not stain with the anti-CYLD antibody. (E-J) Detection of CYLD in adult tissues by immunofluorescence. (E) Negative control using a non-specific rabbit polyclonal antibody (anti-GFP) as primary antibody and the same secondary antibody used in F-J. Using the same settings as in E, endogenous CYLD levels were detected with a rabbit polyclonal anti-CYLD antibody on adult w1118 sagittal paraffin sections (8 m). CYLD was detected in ovaries (F), in testes (G), in the fat body (H), in the antenna (I) and in the eye (J). amg, anterior midgut rudiment; br, brain; hg, hindgut; mg, midgut; ms, mesoderm; pmg, posterior midgut rudiment; vnc, ventral nerve cord. Fig. 3. Drosophila (Dm)CYLD is a deubiquitylating enzyme. E. coli expressing a ubiquitin- -galactosidase (Ub- gal) fusion were transformed with the indicated expression constructs for glutathione-Stransferase (GST): GST-HCYLD(538-956), GST-DmCYLD or GSTDmCYLD(C284S). (A) After induction of the GST-domain-containing proteins, whole extracts from an approximately equal number of bacteria were analyzed by immunoblotting with a polyclonal anti- galactosidase antibody. The positions of Ub- gal and -galactosidase ( -gal) are indicated. (B) The GST-domain-containing proteins were expressed at similar levels, as detected by immunoblotting of whole-cell lysates of an equal number of bacteria with polyclonal anti-GST antibody. protein remained abundant in the midgut and posterior intestine (Fig. 2C). Together, these data suggest a role for CYLD in the development or function of the midgut and mesodermal derivatives, as well as in the nervous system. In adult flies, CYLD was detected in several tissues. Strong expression was detected in the cytoplasm of nurse and follicle cells in the developing oocyte (Fig. 2F), and in the testes (Fig. 2G). Weaker protein accumulation was detected in intestinal epithelial cells (data not shown) and in the fat body (Fig. 2H). In addition, CYLD accumulated strongly in the proboscis, antenna (Fig. 2I) and in the eye (Fig. 2J), whereas the protein was weakly detectable in various areas of the brain, such as the optic lobe (data not shown). The reactivity of adult tissues to the anti-CYLD antibody could be almost completely eliminated with the addition of excess antigen that was used to raise the antibody (data not shown). Drosophila CYLD has deubiquitylating activity The high degree of similarity between the ubiquitin-specific protease domain of human CYLD and the corresponding Cterminal region of Drosophila CYLD prompted an investigation into the ability of Drosophila CYLD to act as a deubiquitylating enzyme. For this purpose, Drosophila CYLD was introduced into bacteria expressing a ubiquitin- -galactosidase (Ub- gal) fusion, and its ability to cleave the ubiquitin moiety from the Ub- gal fusion protein was tested. Wild-type Drosophila CYLD readily cleaved ubiquitin from the Ub- gal fusion (Fig. 3, compare lanes 1 and 3). By contrast, a mutated form of Drosophila CYLD, containing a serine instead of a conserved cysteine in the putative catalytic domain, was unable to cleave ubiquitin from the Ub- gal fusion (Fig. 3, compare lanes 1 and 4). As expected, human CYLD was also capable of cleaving the Ub- gal fusion (Fig. 3, reverse transcriptase (RT)-PCR, and CYLD-specific transcripts were found in all developmental stages (embryo, larva and pupa) and in all three major adult body segments (Fig. 1B). The protein distribution pattern was then investigated using an anti-CYLD antibody that we developed (see Materials and methods). The specificity of this antibody to Drosophila CYLD was confirmed because embryos homozygous for the Df(2L)J21 deficiency, which deletes the 31C7D1 chromosomal area in which CYLD resides, did not show any reactivity to the antibody (Fig. 2D). Drosophila CYLD was present throughout stage 1-5 embryos (data not shown) but, by stage 7, the protein was detected mainly in mesoderm and in developing segments of the anterior and posterior midgut (Fig. 2A). During embryonic stage 12, CYLD continued to accumulate in the developing midgut and was relatively abundant in the brain and ventral nerve cord (Fig. 2B). By embryonic stage 14, accumulation of CYLD in the brain and ventral nerve cord was notably stronger than that of earlier stages, while the DEVELOPMENT CYLD regulates fat content and host defense RESEARCH ARTICLE 2609 Fig. 4. Molecular characterization of P-element insertion lines. (A) The positions of P-element insertions analyzed and the primers that were used [DMCYLDF3 (DCYF3), DMCYLDR6 (DCYR6), DMCYLDF7 (DCYF7) and DMCYLDR9 (DCYR9)] are shown relative to the five transcripts of Drosophila CYLD that have been identified. (B) The Pelement-insertion lines f00135, f00814, f02492 and d10472 were analyzed by reverse transcriptase (RT)-PCR for CYLD mRNA. The results were compared with wild-type flies (w1118). rp49 (also known as RpL32) RNA was used as a control for the amount of cDNA used in the RT-PCR reaction (lower panel). Fig. 5. Impaired Drosophila CYLD expression alters fat body morphology. (A-C) Adult female abdomens from wild-type (A), CYLDf00814 homozygotes (B) and CYLD-rescue (C) flies were analyzed by hematoxylin and Eosin staining of paraffin sections (8 m). (D-F) Oocyte morphology in wild-type (D), CYLDf00814 homozygotes (E) and CYLD-rescue (F) flies. (G,H) Nile red staining for the presence of lipid droplets in cryosections from adult wild-type flies (G) or CYLDf00814 homozygotes (H). lane 2). Therefore, like its vertebrate ortholog, Drosophila CYLD has autonomous deubiquitylating activity that depends on the integrity of its conserved C-terminal catalytic domain. Defective expression of Drosophila CYLD alters fat body morphology In order to study the biological role of CYLD in Drosophila, four strains containing P-element insertions in the CYLD locus were obtained from the Exelixis collection. The genomic locations of all transposons were verified by PCR (data not shown). Strain f00814, which contains a P-element insertion in the first intron (Fig. 4A), was chosen for further analysis because this allele can be considered a strong CYLD hypomorph lacking detectable expression of all possible transcripts from the gene (Fig. 4B). By contrast, the insertions in intron 2 of Drosophila CYLD either did not appear to disrupt or disrupted incompletely the expression of CYLD-associated mRNAs in the f00135, f02494 and d10472 strains. Consistent with the RT-PCR analysis, staining of f00814 homozygous-mutant embryos with anti-CYLD antibody failed to detect CYLD protein (data not shown). Therefore, this strain represents a bona fide mutant allele of the gene, henceforth called CYLDf00814. Given the protein distribution in developing embryos, CYLDf00814 homozygotes were surprisingly viable and did not exhibit obvious external morphological anomalies. This indicates that Drosophila CYLD function is either dispensable for proper embryonic development, or it is functionally redundant with another gene in the genome. However, histological analysis revealed that the majority of CYLDf00814 adult homozygotes exhibited fat body cells of an abnormal size and morphology (Fig. 5B, Table 1). This phenotype was reversed upon inducible expression of a CYLD transgene under the control of the heat-shock promoter in the CYLDf00814 mutant background (UAS-CYLD/+;CYLDf00814;hs-Gal4/MKRS, referred to as the CYLD-rescue strain from this point on) (Fig. 5C, Table 1). The absence of CYLD did not precipitate apparent morphological defects in other tissues and organs [compare the oocyte from wild-type (Fig. 5D), f00814 (Fig. 5E) and CYLD-rescue (Fig. 5F) flies]. Nile red staining showed that fat body cells in CYLDf00814 adult homozygotes were able to accumulate lipids. This in turn indicated that they retained a degree of functionality despite their morphological Table 1. Fat body morphology in wild-type and CYLDf00814 mutant flies Moderate alteration (%) Severe alteration (%) Genotype WT (%) w1118 CYLDf00814 CYLD rescue 93.33 26.66 90.00 � 26.67 10.00 � 46.67 � A total of 30 adult female flies of each genotype were analyzed for the morphology of the fat body. The percentage of flies with normal (WT), moderately altered or severely altered fat body is shown (see also Results and Fig. 5). In 2/30 (6.67%) w1118 flies, the morphology of the fat body could not be determined. DEVELOPMENT Fat body morphology 2610 RESEARCH ARTICLE Development 134 (14) A 800 700 �g TAG / mg protein * 600 500 400 300 200 100 0 WT (w1118) f00814 DmCYLD rescue DmCYLD rescue(NO HS) B 100 90 80 70 60 50 40 30 20 10 0 % survival WT (w1118) f00814 DmCYLD rescue 0 12 24 36 48 60 72 84 time (hr) 96 108 120 132 144 Fig. 6. Impaired Drosophila CYLD expression results in elevated triglyceride content and increased survival under starvation. (A) Triglyceride (TAG) content (expressed as g TAG per g protein) of 2-3-day-old male flies after hatching. The following strains were analyzed: wild type (WT) w1118, CYLDf00814 homozygotes (f00814), UAS-CYLD/Y;CYLDf00814;hs-Gal4/MKRS (DmCYLD rescue) after heatshock induction of UAS-CYLD transcription and CYLD-rescue flies that were not subjected to heat-shock [DmCYLD rescue(NO HS)]. Mean values (�s.d.) from at least three independent experiments are shown. (B) Survival under starvation conditions of 2-3-day-old male flies. Representative data from at least three independent experiments are shown. Fig. 7. Drosophila CYLD (DmCYLD) interacts with Kenny (dIKK ). (A) Quantitative yeast two-hybrid assay with all of the components of the IMD pathway (PGRP-LC, PGRP-LE, PGRP-LA, IMD, dTAK1, dFADD, DREDD, IRD5 and Kenny). CYLD interacts specifically with Kenny, the Drosophila ortholog of the mammalian protein NEMO (IKK ). (B) AntiV5 western blot of anti-c-Myc-immunoprecipitated material from lysates of Drosophila S2 cells transfected with plasmids expressing the proteins indicated on the top of the panel. alterations (Fig. 5G,H). A measurement of lipid droplets revealed that CYLDf00814 adult homozygotes had significantly more but smaller lipid droplets (5.77�0.26 lipid droplets cm�2) compared to the wildtype strain w1118 (3.08�0.20 lipid droplets cm�2). Defective expression of Drosophila CYLD is associated with increased total triglyceride content The altered morphology of the fat body prompted an investigation into the fat content of flies with defective CYLD expression. The fat body is the major site of fat storage in Drosophila. Fat is stored primarily in the form of triglycerides (TAGs) in characteristic structures called lipid droplets. These structures consist of a single phospholipid layer that surrounds the TAGs. They are opaque and usually occupy a large portion of the cell, thus restricting the cytoplasm and nucleus to one side, and therefore contributing to the characteristic morphology of the fat body (Gronke et al., 2005). Total TAG content was found to be inversely proportional to the level of Drosophila CYLD expression. More specifically, total TAGs were increased by 79.8% in CYLDf00814 adult homozygotes compared with control animals (Fig. 6A). However, CYLDf00814 homozygotes that expressed transgenic Drosophila CYLD contained almost wild-type levels of TAGs (CYLD rescue, Fig. 6A). Significantly, in the absence of the heat-shock required for the expression of Drosophila CYLD transgenes, UASCYLD/Y;CYLDf00814;hs-Gal4/MKRS flies possessed a TAG content that was not significantly different from that of CYLDf00814 homozygotes [Fig. 6A, CYLD rescue (NO HS)]. Therefore, our data suggest that Drosophila CYLD is required for TAG homeostasis, a function that is most likely related to the altered morphology of the fat body in CYLDf00814 homozygotes. Defective expression of Drosophila CYLD is associated with increased resistance to nutrient starvation The increased levels of TAGs in flies with impaired CYLD expression suggested that CYLDf00814 homozygotes might be able to survive for longer periods of time under starvation conditions. For this purpose, newly emerged adults were allowed to feed normally for up to 36 hours and were then placed in vials without food but with free access to water. CYLDf00814 homozygotes survived significantly longer without a source of nutrients in comparison with controls (Fig. 6B). Control animals and CYLD-rescue flies were dead after 4 days, whereas more than 40% of CYLDf00814 homozygotes remained alive at the end of this time period. Heatshock did not significantly alter the resistance to starvation of control DEVELOPMENT CYLD regulates fat content and host defense RESEARCH ARTICLE 2611 A 1. 8 1. 6 1. 4 1. 2 1 0. 8 0. 6 0. 4 0. 2 0 Diptericin expression 6h after infection A 120 100 % flies surviving 80 60 40 20 E. coli WT f00814 relish DmCYLD rescue Dipt/RP49 normalised w uninfected f00814 w E. coli f00814 B 1. 2 DmCYLD overexpression 1 0 Day 0 Day 1 Day 2 Day 3 Day 4 Time Day 5 Day 6 Day 7 Dipt/RP49 normalised B 0. 8 0. 6 0. 4 0. 2 120 100 % flies surviving 80 60 40 20 0 Day 0 Day 1 E. faecalis WT Dif f00814 DmCYLD rescue w DmCYLD/yolk w uninfected E.coli DmCYLD/yolk 0 Day 2 Fig. 8. Antimicrobial peptide expression in flies with impaired Drosophila CYLD expression. (A) Diptericin expression [expressed as a ratio of Diptericin:rp49 (also known as RpL32) mRNA levels] in wildtype w1118 flies (w) and in CYLDf00814 homozygotes (f00814) was determined before and after infection with E. coli. (B) Diptericin expression (expressed as a ratio of Diptericin:rp49 mRNA levels) in wildtype w1118 (w) and flies overexpressing CYLD in the fat body (DmCYLD/yolk) before and after E. coli infection. (A,B) Mean values (�s.d.) from three independent experiments are shown. Day 3 Day 4 Time Day 5 Day 6 Day 7 Fig. 9. A Drosophila strain with impaired CYLD expression is susceptible to infection by Gram-negative and Gram-positive bacteria. (A,B) A total of 25 flies were infected with either Gramnegative (E. coli; A) or Gram-positive (E. faecalis; B) bacteria. Survival was monitored for 7 days. Representative data from one out of four independent experiments are shown in each panel. WT, w1118 wild type; relish/Dif, positive controls; f00814: CYLDf00814 homozygotes. animals (data not shown). Collectively, the data suggest that reduced levels of CYLD result in an elevation in the levels of TAGs, which is the most likely cause of the observed resistance to starvation of CYLDf00814 homozygotes. Defective expression of Drosophila CYLD is associated with susceptibility to bacterial infections Because of the deficits in fat body structure and function described above, and the known principal role of this organ in Drosophila host defence, we wanted to determine whether loss of Drosophila CYLD altered susceptibility to infections. Furthermore, this would be consistent with the given connection of mammalian CYLD with NFB/IKK signaling and with the function of the immune system (Brummelkamp et al., 2003; Kovalenko et al., 2003; Reiley et al., 2006; Trompouki et al., 2003). The hallmark of the Drosophila systemic immune response is the synthesis and secretion by the fat body of potent AMPs. Although these responses have broad specificity, their pattern of expression depends largely on the type of invading pathogen (Naitza and Ligoxygakis, 2004). Whereas anti-fungal and anti-Gram-positive bacterial responses are controlled by the Toll signaling cascade, Gram-negative sepsis depends on the IMD pathway, the Drosophila homolog of mammalian TNFR signaling (Kaneko and Silverman, 2005). In human cells, CYLD interacts with NEMO and regulates the activation of NF- B by deubiquitylating signaling molecules of TNFR-associated pathways (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003). We used a quantitative yeast two-hybrid assay to investigate the ability of Drosophila CYLD to interact with known members of the IMD pathway in Drosophila (PGRP-LC, PGRP-LE, IMD, dFADD, DREDD, dTAK1, IRD5 and KENNY). We found that Drosophila CYLD was able to interact with KENNY, which is the Drosophila counterpart of the mammalian NEMO (IKK ) protein, but not with other proteins implicated in the IMD pathway (Fig. 7A). The interaction between CYLD and KENNY was confirmed via coimmunoprecipitation in Schneider-2 (S2) cells (Fig. 7B). Next, we investigated the effect of impaired Drosophila CYLD expression on Toll and IMD signaling with and without infection, by measuring the expression of the AMP genes Diptericin (Dipt; DptB) and Drosomycin (Drs) as read-outs for IMD and Toll signaling, respectively. In uninfected flies, Dipt expression in mutant homozygotes was significantly higher than in wild-type flies, whereas no significant difference was observed between CYLDf00814 homozygotes and wild-type flies upon infection with Escherichia coli (Fig. 8A). No significant difference in Drs expression was detected between mutant and wild-type flies without infection or following Gram-positive bacterial challenge (data not shown), suggesting that Drosophila CYLD does not regulate the Toll pathway. DEVELOPMENT 2612 RESEARCH ARTICLE Development 134 (14) In addition, we also studied the effects of a gain-of-function condition for Drosophila CYLD, whereby UAS-CYLD flies were crossed to the fat body-specific yolk-GAL4 driver and Dipt gene expression was measured (Fig. 8B). Dipt induction was significantly below that of wild type in infected flies. Interestingly, following infection with Gram-positive or Gramnegative bacteria, CYLDf00814 homozygotes exhibited a reduced rate of survival compared with wild type (Fig. 9). Flies from this strain showed reduced survival after infection by the Gram-negative bacterium E. coli (Fig. 9A) or by the Gram-positive bacterium Enterococcus faecalis (Fig. 9B), compared with wild-type or CYLD-rescued flies. Parallel experiments with the CYLDf00814 allele over a deficiency uncovering the Drosophila CYLD locus produced comparable results (data not shown). This was not the case when heat-killed bacteria were used (data not shown). Notably, restoration of Drosophila CYLD expression in CYLD-rescue flies also restored the ability of these flies to respond to both kinds of challenges (Fig. 9, CYLD-rescue curves). Taken together, these results identify a crucial role of CYLD in anti-bacterial responses in Drosophila. DISCUSSION Drosophila melanogaster is emerging as one of the most effective tools for analyzing the function of human disease genes, including those responsible for developmental and neurological disorders, cancer, cardiovascular disease, metabolic and storage diseases, and genes required for the function of the visual, auditory and immune systems. Flies have several experimental advantages, including their rapid life cycle and the large numbers of individuals that can be generated, which make them ideal for sophisticated genetic screens (Bier, 2005). In the present study, we characterized the expression and function of the Drosophila ortholog of the human tumor suppressor gene CYLD. Flies with impaired Drosophila CYLD expression showed severe susceptibility to bacterial infection. By inference from its human counterpart, which is a negative regulator of TNF/NF- B signaling, it can be hypothesized that IMD-mediated AMP gene expression would be upregulated in CYLD loss-of-function mutant flies, whereas a gain-of-function condition should have the opposite effect. As expected, overexpressing Drosophila CYLD suppressed IMD signaling in uninfected and infected flies. In uninfected null mutants, Dipt expression was twice as high as in wild-type flies. Interestingly, Dipt levels in infected CYLD mutants were not significantly different from wild-type flies, whereas basal levels were elevated in comparison with wild-type controls. The most likely reason for this is that, when septic injury is used as a means of infection, the system is overloaded and Dipt expression reaches its maximum, such that even when an inhibitor of IMD signaling is eliminated, any further increase is not possible. To our knowledge, this article is the first to describe a deubiquitylating enzyme implicated in the regulation of NF- B signaling in Drosophila. Furthermore, the discovery that the loss of Drosophila CYLD leads to a concomitant increase in Dipt expression suggests that the IMD pathway, like its mammalian counterpart (the TNFR pathway), is activated by ubiquitylation. Our results suggest that Drosophila IKK is a likely target for this activation. Its interaction with Drosophila CYLD could serve as a switch to de-activate the pathway, as has been proposed for the NEMO-CYLD interaction in mammals (Brummelkamp et al., 2003; Kovalenko et al., 2003; Trompouki et al., 2003). An additional IKKregulating deubiquitylating enzyme, A20 (also known as Tnfaip3 � Mouse Genome Informatics), has been described in mice. The knock-out effect of its gene has revealed a crucial function in limiting inflammation by terminating TNF -induced NF- B responses (Lee et al., 2000). More-recent experiments have revealed that it is, at the same time, a deubiquitylase of K63-linked polyubiquitin chains, and it promotes K48-linked polyubiquitylation of RIP1 (Boone et al., 2004; Evans et al., 2004; Wertz et al., 2004). Drosophila contains an ortholog of A20, and P-element insertions in the 5 untranslated region (UTR) of this gene have an immune phenotype (A.E.B. and P.L., unpublished). Systematic screening for deubiquitylating enzymes in the fly should strengthen the concept of the non-degradative function of polyubiquitin chains in NF- B signaling. De-regulation of the IMD pathway, as exemplified by the observed alteration in Dipt regulation, cannot account, however, for the distinct sensitivity of the Drosophila CYLD mutants to infection. Although measuring AMP gene expression is a good indication of the humoral aspect of the response, overall survival to overt infection is a more general phenomenon involving several pathways and cellular activities (Boutros et al., 2002). An intriguing explanation for the death of CYLDf00814 homozygotes following infection could be offered by the dramatic change in fat body morphology and physiology. The fat body is the major immuno-responsive organ during Drosophila systemic defence and significant changes would be expected to influence survival to immune challenges. Interestingly, a recent report has identified a crucial role for murine CYLD in the development of T lymphocytes (Reiley et al., 2006). Whether higher fat levels could potentially be detrimental as well, remains to be established. A possible hypothesis could be that fly hemocytes, which are macrophage-like cells (Meister and Lagueux, 2003), are not able to engage in phagocytosis because they are overloaded with the function of internalizing excess lipids (that could presumably accumulate in the blood). In the absence of phagocytic activity, bacteria could proliferate freely and kill the host. Following the same line of thinking, mutants with high blood TAGs would also be sensitive to infection. Flies mutant for brummer (bmm), a TAG lipase homologous to human adipocyte TAG lipase, have 100% more TAGs in their blood than their wild-type counterparts (Gronke et al., 2005). Nevertheless, bmm flies showed a survival typical of wild-type flies when challenged with Grampositive or Gram-negative bacteria (data not shown). This finding indicates that high levels of TAGs are not sufficient to cause immune deficiency and strengthens our hypothesis that fat body structure and function might be the principal determinant of immune deficiency in CYLDf00814 homozygotes. Collectively, findings by Reiley et al. (Reiley et al., 2006) together with the results of this study establish a clear functional relationship between mammalian and Drosophila CYLD proteins in host defence. Even though the analysis of CYLD activity in cell lines suggests that it functions as a general negative regulator of IKK and JNK activation by cleaving UbLys63 chains, cylindromatosis patients display a phenotype that is restricted to epidermal body regions. The TNFR family member ectodysplasin A receptor controls the development of epidermal appendices by activating NF- B (Schmidt-Ullrich et al., 2001). Therefore, under physiological conditions, the role of CYLD may be restricted to specific cell types and stimulatory conditions, which points to a functional redundancy with other ubiquitin hydrolases. Similarly, our analysis showed a broad pattern of Drosophila CYLD expression in both embryonic and adult tissues. However, a compromise of CYLD expression did not appear to affect embryonic development, but rather the major effect we observed was restricted to the fat body and the physiological properties attached to it (fat storage, host defence). Again, redundancy with proteins performing similar functions in DEVELOPMENT CYLD regulates fat content and host defense RESEARCH ARTICLE 2613 H. L. and Kessler, B. M. (2002). Chemistry-based functional proteomics reveals novel members of the deubiquitinating enzyme family. Chem. Biol. 9, 1149-1159. Boutros, M., Agaisse, H. and Perrimon, N. (2002). Sequential activation of signaling pathways during innate immune responses in Drosophila. Dev. Cell 3, 711-722. Brogiolo, W., Stocker, H., Ikeya, T., Rintelen, F., Fernandez, R. and Hafen, E. (2001). An evolutionarily conserved function of the Drosophila insulin receptor and insulin-like peptides in growth control. Curr. Biol. 11, 213-221. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. and Bernards, R. (2003). Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NFkappaB. Nature 424, 797-801. Chen, X. and Fischer, J. A. (2000). In vivo structure/function analysis of the Drosophila fat facets deubiquitinating enzyme gene. Genetics 156, 1829-1836. Clancy, D. J., Gems, D., Harshman, L. G., Oldham, S., Stocker, H., Hafen, E., Leevers, S. J. and Partridge, L. (2001). Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292, 104-106. Costello, C. M., Mah, N., Hasler, R., Rosenstiel, P., Waetzig, G. H., Hahn, A., Lu, T., Gurbuz, Y., Nikolaus, S., Albrecht, M. et al. (2005). Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays. PLoS Med. 2, e199. Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C. and Chen, Z. J. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351-361. Evans, P. C., Ovaa, H., Hamon, M., Kilshaw, P. J., Hamm, S., Bauer, S., Ploegh, H. L. and Smith, T. S. (2004). Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378, 727-734. Georgel, P., Naitza, S., Kappler, C., Ferrandon, D., Zachary, D., Swimmer, C., Kopczynski, C., Duyk, G., Reichhart, J. M. and Hoffmann, J. A. (2001). Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev. Cell 1, 503-514. Goberdhan, D. C. and Wilson, C. (2003). The functions of insulin signaling: size isn't everything, even in Drosophila. Differentiation 71, 375-397. Gronke, S., Beller, M., Fellert, S., Ramakrishnan, H., Jackle, H. and Kuhnlein, R. P. (2003). Control of fat storage by a Drosophila PAT domain protein. Curr. Biol. 13, 603-606. Gronke, S., Mildner, A., Fellert, S., Tennagels, N., Petry, S., Muller, G., Jackle, H. and Kuhnlein, R. P. (2005). Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila. Cell Metab. 1, 323-330. Hedengren, M., Asling, B., Dushay, M. S., Ando, I., Ekengren, S., Wihlborg, M. and Hultmark, D. (1999). Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol. Cell 4, 827-837. Ikeda, F. and Dikic, I. (2006). CYLD in ubiquitin signaling and tumor pathogenesis. Cell 125, 643-645. Kaneko, T. and Silverman, N. (2005). Bacterial recognition and signaling by the Drosophila IMD pathway. Cell. Microbiol. 7, 461-469. Kelliher, M. A., Grimm, S., Ishida, Y., Kuo, F., Stanger, B. Z. and Leder, P. (1998). The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity 8, 297-303. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. and Courtois, G. (2003). The tumour suppressor CYLD negatively regulates NFkappaB signaling by deubiquitination. Nature 424, 801-805. Lee, E. G., Boone, D. L., Chai, S., Libby, S. L., Chien, M., Lodolce, J. P. and Ma, A. (2000). Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. Science 289, 2350-2354. Leulier, F., Vidal, S., Saigo, K., Ueda, R. and Lemaitre, B. (2002). Inducible expression of double-stranded RNA reveals a role for dFADD in the regulation of the antibacterial response in Drosophila adults. Curr. Biol. 12, 996-1000. Lu, Y., Wu, L. P. and Anderson, K. V. (2001). The antibacterial arm of the drosophila innate immune response requires an IkappaB kinase. Genes Dev. 15, 104-110. Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. and Fassler, R. (2006). Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NFkappaB signaling. Cell 125, 665-677. Meister, M. and Lagueux, M. (2003). Drosophila blood cells. Cell. Microbiol. 5, 573-580. Naitza, S. and Ligoxygakis, P. (2004). Antimicrobial defences in Drosophila: the story so far. Mol. Immunol. 40, 887-896. Naitza, S., Rosse, C., Kappler, C., Georgel, P., Belvin, M., Gubb, D., Camonis, J., Hoffmann, J. A. and Reichhart, J. M. (2002). The Drosophila immune defense against gram-negative infection requires the death protein dFADD. Immunity 17, 575-581. Philip, N., Acevedo, S. F. and Skoulakis, E. M. (2001). Conditional rescue of olfactory learning and memory defects in mutants of the 14-3-3zeta gene leonardo. J. Neurosci. 21, 8417-8425. Regamey, A., Hohl, D., Liu, J. W., Roger, T., Kogerman, P., Toftgard, R. and Huber, M. (2003). The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor. J. Exp. Med. 198, 1959-1964. other tissues could be envisaged (Chen and Fischer, 2000). Nevertheless, possible functional deficits in the nervous system, where Drosophila CYLD accumulates, were not investigated in CYLDf00814 animals, but will be the focus of future experiments. We demonstrated that impaired Drosophila CYLD expression is associated with increased TAG content and resistance to nutrient starvation. This result suggests that CYLD is involved in fat storage and/or metabolism in Drosophila, and possibly in mammals. Increased TAG content has been observed in flies with mutated insulin receptor (INR) or Chico, an INR substrate (Bohni et al., 1999; Clancy et al., 2001; Tatar et al., 2001). Therefore, it is possible that Drosophila CYLD is required for proper signal transduction by INR. INR is activated by neuropeptides [insulin-related peptides (ILPs)] homologous to human insulin (Brogiolo et al., 2001). We have found that the expression of Drosophila ILP2, the major ILP, is not affected by the decrease in CYLD levels (data not shown). This finding suggests that Drosophila CYLD might regulate INR signaling downstream of receptor activation. One such possible target is the transcription factor FOXO, which is activated by INR signaling (Goberdhan and Wilson, 2003). It has been shown that FOXO is activated by the JNK pathway, which itself was recently shown to be negatively regulated by CYLD in mammalian cells (Reiley et al., 2004; Wang et al., 2005). In Drosophila, activation of the JNK pathway contributes to oxidative stress resistance (Wang et al., 2003), and this, in conjunction with increased TAG levels observed in CYLD-deficient flies, might explain the resistance of CYLDf00814 homozygotes to nutrient starvation. Further analysis is required to determine whether Drosophila CYLD, like its human counterpart, is also involved in the regulation of the JNK pathway, establishing further the valuable cross-talk between flies and humans in the context of understanding disease. The authors would like to thank I. Livadaras and C. Savakis (Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology, Heraklion, Greece) for advice and technical assistance with the generation of transgenic flies; the curators of the Exelixis collection for providing the mutant strains used in this study; D. Sherratt (University of Oxford) for the use of the Fuji-film FLA 3000 phosphorimager; and Steve Tronick (Santa Cruz Biotechnology) for assistance with the generation of the anti-CYLD antibody. This work was supported by an international scholarship from the Howard Hughes Medical Institute and by funding under the Sixth Research Framework Programme of the European Union, Project INCA (LSHCCT-2005-018704) (to G.M.) and by a Career Establishment Grant from the Medical Research Council UK (to P.L.). G.M. is a Scholar of the Leukemia and Lymphoma Society of America. References Bier, E. (2005). Drosophila, the golden bug, emerges as a tool for human genetics. Nat. Rev. Genet. 6, 9-23. Biggs, P. J., Wooster, R., Ford, D., Chapman, P., Mangion, J., Quirk, Y., Easton, D. F., Burn, J. and Stratton, M. R. (1995). Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat. Genet. 11, 441-443. Biggs, P. J., Chapman, P., Lakhani, S. R., Burn, J. and Stratton, M. R. (1996). The cylindromatosis gene (cyld1) on chromosome 16q may be the only tumour suppressor gene involved in the development of cylindromas. Oncogene 12, 1375-1377. Bignell, G. R., Warren, W., Seal, S., Takahashi, M., Rapley, E., Barfoot, R., Green, H., Brown, C., Biggs, P. J., Lakhani, S. R. et al. (2000). Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160165. Bohni, R., Riesgo-Escovar, J., Oldham, S., Brogiolo, W., Stocker, H., Andruss, B. F., Beckingham, K. and Hafen, E. (1999). Autonomous control of cell and organ size by CHICO, a Drosophila homolog of vertebrate IRS1-4. Cell 97, 865875. Boone, D. L., Turer, E. E., Lee, E. G., Ahmad, R. C., Wheeler, M. T., Tsui, C., Hurley, P., Chien, M., Chai, S., Hitotsumatsu, O. et al. (2004). The ubiquitinmodifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060. Borodovsky, A., Ovaa, H., Kolli, N., Gan-Erdene, T., Wilkinson, K. D., Ploegh, DEVELOPMENT 2614 RESEARCH ARTICLE Reiley, W., Zhang, M. and Sun, S. C. (2004). Negative regulation of JNK signaling by the tumor suppressor CYLD. J. Biol. Chem. 279, 55161-55167. Reiley, W. W., Zhang, M., Jin, W., Losiewicz, M., Donohue, K. B., Norbury, C. C. and Sun, S. C. (2006). Regulation of T cell development by the deubiquitinating enzyme CYLD. Nat. Immunol. 7, 411-417. Rutschmann, S., Jung, A. C., Hetru, C., Reichhart, J. M., Hoffmann, J. A. and Ferrandon, D. (2000a). The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity 12, 569-580. Rutschmann, S., Jung, A. C., Zhou, R., Silverman, N., Hoffmann, J. A. and Ferrandon, D. (2000b). Role of Drosophila IKK gamma in a toll-independent antibacterial immune response. Nat. Immunol. 1, 342-347. Schmidt-Ullrich, R., Aebischer, T., Hulsken, J., Birchmeier, W., Klemm, U. and Scheidereit, C. (2001). Requirement of NF-kappaB/Rel for the development of hair follicles and other epidermal appendices. Development 128, 3843-3853. Silverman, N., Zhou, R., Stoven, S., Pandey, N., Hultmark, D. and Maniatis, T. (2000). A Drosophila IkappaB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 14, 2461-2471. Skoulakis, E. M. and Davis, R. L. (1996). Olfactory learning deficits in mutants for leonardo, a Drosophila gene encoding a 14-3-3 protein. Neuron 17, 931944. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E. and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523. Stoven, S., Silverman, N., Junell, A., Hedengren-Olcott, M., Erturk, D., Engstrom, Y., Maniatis, T. and Hultmark, D. (2003). Caspase-mediated processing of the Drosophila NF-kappaB factor Relish. Proc. Natl. Acad. Sci. USA 100, 5991-5996. Development 134 (14) Tatar, M., Kopelman, A., Epstein, D., Tu, M. P., Yin, C. M. and Garofalo, R. S. (2001). A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292, 107-110. Thibault, S. T., Singer, M. A., Miyazaki, W. Y., Milash, B., Dompe, N. A., Singh, C. M., Buchholz, R., Demsky, M., Fawcett, R., Francis-Lang, H. L. et al. (2004). A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat. Genet. 36, 283-287. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. and Mosialos, G. (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424, 793-796. Vidal, S., Khush, R. S., Leulier, F., Tzou, P., Nakamura, M. and Lemaitre, B. (2001). Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-kappaB-dependent innate immune responses. Genes Dev. 15, 1900-1912. Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J. and Chen, Z. J. (2001). TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412, 346-351. Wang, M. C., Bohmann, D. and Jasper, H. (2003). JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell 5, 811-816. Wang, M. C., Bohmann, D. and Jasper, H. (2005). JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121, 115-125. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L. et al. (2004). De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signaling. Nature 430, 694-699. Zhou, R., Silverman, N., Hong, M., Liao, D. S., Chung, Y., Chen, Z. J. and Maniatis, T. (2005). The role of ubiquitination in Drosophila innate immunity. J. Biol. Chem. 280, 34048-34055. DEVELOPMENT